Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors
To evaluate the differences in action of commercially available 2-oxoglutarate mimetics and "branched-tail" oxyquinoline inhibitors of hypoxia-inducible factor prolyl hydroxylase (HIF PHD), the inhibitors' IC<sub>50</sub> values in the activation of HIF1 ODD-luciferase rep...
Saved in:
Main Authors: | Andrey A. Poloznikov (Author), Sergey V. Nikulin (Author), Dmitry M. Hushpulian (Author), Anna Yu. Khristichenko (Author), Andrey I. Osipyants (Author), Andrey F. Asachenko (Author), Olga V. Shurupova (Author), Svyatoslav S. Savin (Author), Sue H. Lee (Author), Irina N. Gaisina (Author), Gregory R. J. Thatcher (Author), Anthony Narciso (Author), Eric P. Chang (Author), Sergey V. Kazakov (Author), Nancy Krucher (Author), Vladimir I. Tishkov (Author), Bobby Thomas (Author), Irina G. Gazaryan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
by: Andrey A. Poloznikov, et al.
Published: (2021) -
Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
by: Maria Savyuk, et al.
Published: (2020) -
9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells
by: Andrey Poloznikov, et al.
Published: (2021) -
Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice
by: Shunji Nishide, et al.
Published: (2020) -
Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
by: Jie Lun, et al.
Published: (2023)